Gambichler, T.; Gaertner, P.C.; Abu Rached, N.; Susok, L.; Weyer-Fahlbusch, S.S.
Overall Survival of Patients with Melanoma of Unknown Primary Versus Melanoma of Known Primary Under Immunotherapy and Targeted Therapy: A Systematic Review and Meta-Analysis. Dermato 2025, 5, 15.
https://doi.org/10.3390/dermato5030015
AMA Style
Gambichler T, Gaertner PC, Abu Rached N, Susok L, Weyer-Fahlbusch SS.
Overall Survival of Patients with Melanoma of Unknown Primary Versus Melanoma of Known Primary Under Immunotherapy and Targeted Therapy: A Systematic Review and Meta-Analysis. Dermato. 2025; 5(3):15.
https://doi.org/10.3390/dermato5030015
Chicago/Turabian Style
Gambichler, Thilo, Priyanka C. Gaertner, Nessr Abu Rached, Laura Susok, and Sera S. Weyer-Fahlbusch.
2025. "Overall Survival of Patients with Melanoma of Unknown Primary Versus Melanoma of Known Primary Under Immunotherapy and Targeted Therapy: A Systematic Review and Meta-Analysis" Dermato 5, no. 3: 15.
https://doi.org/10.3390/dermato5030015
APA Style
Gambichler, T., Gaertner, P. C., Abu Rached, N., Susok, L., & Weyer-Fahlbusch, S. S.
(2025). Overall Survival of Patients with Melanoma of Unknown Primary Versus Melanoma of Known Primary Under Immunotherapy and Targeted Therapy: A Systematic Review and Meta-Analysis. Dermato, 5(3), 15.
https://doi.org/10.3390/dermato5030015
